Hrt Financial LP Novavax Inc Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $376,810 - $538,933	55,332 New	55,332 $400,000
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $1.08 Million - $3.04 Million	121,545 Added 201.32%	181,919 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.1 Million - $4.6 Million	60,374 New	60,374 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $19.4 Million - $29.6 Million	-109,286 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $4.85 Million - $10.3 Million	40,042 Added 57.83%	109,286 $23.2 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $7.82 Million - $22.2 Million	69,244 New	69,244 $12.6 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $401,022 - $710,473	-5,093 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $404,587 - $909,151	5,093 New	5,093 $551,000
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $106,051 - $431,760	-26,985 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $50,021 - $70,762	13,556 Added 100.95%	26,985 $107,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $53,984 - $105,283	13,429 New	13,429 $67,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.